01/02/23 -"A solid start into the year (1Q on 14 February) might pave the path towards a high-three digit million adjusted EBIT for the full year 2022/23"
01/02/23 -"A solid start into the year (1Q on 14 February) might pave the path towards a high-three digit million adjusted EBIT for the full year 2022/23"
AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.
| Corporate broking | NO |
| Trading in corporate shares | NO |
| Analyst ownership | NO |
| Advising of corporate (strategy, marketing, debt, etc) | NO |
| Research paid for by corporate | NO |
| Provision of corporate access paid for by corporate | NO |
| Link between and a banking entity | NO |
| Brokerage activity at AlphaValue | NO |